Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL6068489

RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available
ChEMBL ↗

Basic Information

ChEMBL ID CHEMBL6068489
Name RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F
Phase Approved
Structure Type NONE
Therapeutic ✓ Yes

Known Names

Abrysvo Arexvy Recombinant respiratory syncytial virus pre-fusion f protein antigen Recombinant stabilized rsv a prefusion f antigen Recombinant stabilized rsv a prefusion f antigen component of abrysvo Recombinant stabilized rsv b prefusion f antigen Recombinant stabilized rsv b prefusion f antigen component of abrysvo Respiratory syncytial virus pre-fusion glycoprotein f
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
8
Known Names
2
Indications
1
Mechanisms

Drug Information

Molecule Type Vaccine component
First Approval 2023
Availability Unknown
Chirality Single Enantiomer
USAN Stem vir-

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Fusion glycoprotein F0 vaccine antigen VACCINE ANTIGEN Fusion glycoprotein F0 ✓ ✓

Indications

Respiratory Syncytial Virus Infections Vaccination

Data from ChEMBL 36 via Core Engine